Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BevCanna, now renamed first to Forte Group Holdings and then to Vanta Holdings, is a Canadian public health-and-wellness consumer products company that originated in cannabis-infused beverages and later shifted toward alkaline/mineralized beverages, nutraceuticals, and white-label manufacturing. The company operates a roughly 40,000-square-foot beverage manufacturing facility in Osoyoos, British Columbia, supplied by an on-site alkaline spring water aquifer, and commercializes products under brands such as TRACE. Through acquisitions including Naturo Group, Pure Therapy, Embark Health, and Greenflame Distribution, it assembled beverage manufacturing, e-commerce, and wellness product capabilities. In 2023, it ceased cannabis beverage and solventless extract operations and surrendered the related Health Canada licenses, making the business more focused on mainstream wellness CPG and nutraceutical products rather than drug development. It is not a therapeutic biotech or pharma developer, but it is healthcare-adjacent through natural health products and nutraceutical commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BevCanna Enterprises.